← back to search

Samith T. Kochuparambil

University of Minnesota Medical Center · US
Area of research
Hematology · Oncology
Research interest
Research interests include Multiple Myeloma Research and Treatments, Hematopoietic Stem Cell Transplantation, Cancer Immunotherapy and Biomarkers, and Photodynamic Therapy Research Studies.
h-index
14
citations
1,315
works
45
NIH funding
primary concept
Medicine
email

Recent publications

Inflammation and mutational burden differentially associated with nivolumab or ipilimumab combination efficacy in colorectal cancer
Nature Communications 2025cited by 5position: middledoi
Lenvatinib Plus Pembrolizumab Versus Sunitinib in First-Line Treatment of Advanced Renal Cell Carcinoma: Final Prespecified Overall Survival Analysis of CLEAR, a Phase III Study
Journal of Clinical Oncology 2024cited by 148position: middledoi
Nivolumab plus ipilimumab for the treatment of post-chemotherapy metastatic castration-resistant prostate cancer (mCRPC): Additional results from the randomized phase 2 CheckMate 650 trial.
Journal of Clinical Oncology 2023cited by 25position: middledoi
Phase 1/2a, open‐label, multicenter study of <scp>RM</scp>‐1929 photoimmunotherapy in patients with locoregional, recurrent head and neck squamous cell carcinoma
Head & Neck 2021cited by 167position: middledoi
RM-1929 photo-immunotherapy in patients with recurrent head and neck cancer: Results of a multicenter phase 2a open-label clinical trial.
Journal of Clinical Oncology 2018cited by 27position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Nilesh Vasan · University of Oklahoma Health Sciences Center2 papers (2018–2021)Frank E. Mott · The University of Texas MD Anderson Cancer Center2 papers (2018–2021)Kerstin Stenson · Rush University Medical Center2 papers (2018–2021)Jennifer M. Johnson · Thomas Jefferson University2 papers (2018–2021)David M. Cognetti · Thomas Jefferson University2 papers (2018–2021)Mohammad Razaq · Mercy Hospital2 papers (2018–2021)John Campana · University of Colorado Denver2 papers (2018–2021)Ann M. Gillenwater · Université Claude Bernard Lyon 12 papers (2018–2021)Joseph Curry · Thomas Jefferson University2 papers (2018–2021)D. McDonald · Medical University of South Carolina2 papers (2018–2021)Mary J. Fidler · Rush University Medical Center2 papers (2018–2021)Beilei He · Novartis (Switzerland)1 papers (2025–2025)Heinz‐Josef Lenz · Keck Hospital of USC1 papers (2025–2025)Gedske Daugaard · Copenhagen University Hospital1 papers (2023–2023)Sara Lonardi · Istituto Oncologico Veneto1 papers (2025–2025)Fred Saad · Cytodiagnostics (Canada)1 papers (2023–2023) · 1 papers (2021–2021)Massimo Aglietta · Istituto Zooprofilattico Sperimentale del Piemonte Liguria e Valle d'Aosta1 papers (2025–2025) · 1 papers (2025–2025)Giuseppe Procopio · Fondazione IRCCS Istituto Nazionale dei Tumori1 papers (2023–2023)